ResMed (RMD) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter increased compared to the prior quarter and rose compared to the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q4
Revenue for the quarter increased compared to the prior quarter and rose compared to the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+2.2%
Change from the immediately preceding quarter.
Year-over-year
+9.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $1.1B | +16.0% |
| Dec 31, 2023 | $1.2B | +12.5% |
| Mar 31, 2024 | $1.2B | +7.2% |
| Jun 30, 2024 | $1.2B | +9.0% |
Revenue performance
Reported revenue moved higher from the immediately preceding quarter, continuing an upward trajectory. The year-over-year comparison also showed a solid increase.
Quarterly comparison
Compared to the prior quarter, revenue improved at a slower pace than the year-over-year increase. The trailing twelve-month revenue reflected sustained growth over the period.
What to watch
The filing notes that cash from operations may fluctuate due to factors including supply chain disruptions and working capital requirements.